Marianne M. Glanzman, MD: Helping ADHD Patients Succeed


Dr. Glanzman presented during AAP 2021 about executive function impairments in patients with ADHD.

Helping a student with attention deficit/hyperactivity disorder (ADHD) matriculate through school takes a committed effort from parents, physicians, teachers, administrators, family members, and friends.

This is especially true during the COVID-19 pandemic, where the transition to hybrid or virtual schooling has become a challenge for students with ADHD to maintain a steady routine.

Recently, during the 2021 American Academy of Pediatrics (AAP) virtual conference, Marianne M. Glanzman, MD, Attending Physician, Department of Developmental and Behavioral Pediatrics, Children’s Hospital of Philadelphia (CHOP), presented a session about executive function in patients with ADHD.

Executive functions are basically the ability to accomplish goal-directed behavior, including working memory, behavioral inhibition, and cognitive flexibility. However, Glanzman said those are most common impairments, they are not the only impairments. In fact there are about 33 different constructs considered part of executive function.

In an interview with HCPLive®, Glanzman explained how important it is for all aspects of the patient’s life to be pulling in the same direction and executive function should be a major part of that.

She said 1 area where ADHD care can improve is physicians should give parents guidance on how ADHD impacts executive function and what they can do to better help their child.

“As this term executive function becomes much, much more front and center in the world of ADHD, I think parents are going to be asking physicians for advice on this topic,” Glanzman said.

Recent Videos
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
Veeral Sheth, MD: Assessment of EYP-1901 Supplemental Injection Use in Wet AMD | Image Credit: University Retina
Boadie Dunlop, MD, Weighs in on FDA Advisory Vote on Lykos’ MDMA
Viability of Elamipretide for Geographic Atrophy in Dry AMD | Image Credit: HCPLive
Advancing Elamipretide into Phase 3 ReNEW and ReGAIN Trials | Image Credit: HCPLive
© 2024 MJH Life Sciences

All rights reserved.